ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2023, Vol. 32 ›› Issue (2): 115-120.DOI: 10.3969/j.issn.1006-298X.2023.02.003

• • 上一篇    下一篇

肾脏风险评分和肾血管病变评分对抗中性粒细胞胞质抗体相关肾小球肾炎预后的预测价值

张晓枫, 王欣芳, 陈琳, 王瑞强   

  • 出版日期:2023-04-28 发布日期:2023-04-24

Predictive value of renal risk score and renal vascular lesions score on renal prognosis in antineutrophil cytoplasmic antibodyassociated glomerulonephritis

ZHANG Xiaofeng, WANG Xinfang, CHEN Lin, WANG Ruiqiang   

  • Online:2023-04-28 Published:2023-04-24

摘要: 目的:评估肾脏风险评分(RRS)和肾血管病变(RVLs)评分对抗中性粒细胞胞质抗体相关性肾小球肾炎(AAGN)的肾脏预后预测价值。
方法:收集2014年4月至2021年5月于郑州大学第一附属医院诊断为AAGN的患者资料。计算RRS和RVLs评分并分组,分析RRS和RVLs评分与临床病理和肾脏预后的关系及其对肾脏预后的预测价值。
结果:137例患者中,38例进展为终末期肾病。高RRS组和重度RVLs组的血清肌酐、透析依赖性、收缩压分别显著高于低RRS组和无RVLs组,估算的肾小球滤过率、正常肾小球百分比分别显著低于低RRS组和无RVLs组(P<0.05)。生存分析显示,高、中RRS组的肾脏预后差于低RRS组(P均<0.001)。在RVLs组内,重度RVLs组的肾脏预后差于中度、轻度和无RVLs组(P均<0.001)。ROC分析显示,RRS、RVLs评分、RRS联合RVLs评分的3年肾生存曲线下面积分别为0.860、0.789、0.919,RRS与RVLs评分的预测能力相当,而RRS联合RVLs评分的预测能力更优。
结论:在AAGN中,RRS联合RVLs评分对肾脏预后的预测价值优于RRS和RVLs评分,其可作为新的预测指标。


关键词: 抗中性粒细胞胞质抗体相关性肾小球肾炎, 肾脏风险评分, 肾血管病变评分, 肾脏预后

Abstract: Objective:To evaluate predictive value of the renal risk score (RRS) and renal vascular lesions (RVLs) score for renal prognosis in Antineutrophil cytoplasmic antibody-associated glomerulonephritis (AAGN).
Methodology:Patients diagnosed with AAGN at the First Affiliated Hospital of Zhengzhou University from April 2014 to May 2021 were collected. RRS and RVLs score were calculated based on results of renal biopsy and analyzed for their relationship with clinicopathological feature and renal prognosis.
Results:A total of 137 patients were enrolled, 38 patients progressed to end-stage kidney disease. Serum creatinine, dialysis dependence, and systolic blood pressure were significantly higher in the high RRS and severe RVLs groups than in the low RRS and without RVLs groups, respectively, and the estimated glomerular filtration rate and percentage of normal glomeruli were significantly lower than in the low RRS and without RVLs groups, respectively. Survival analysis showed that within the RRS group, the renal prognosis was worse in the high and moderate RRS groups than that in the low RRS group (P<0.001). Within the RVLs group, the renal prognosis was worse in the severe RVLs group than that in the moderate, mild, and without RVLs groups (P<0.001). ROC analysis showed that the area under the 3-year renal survival curve for RRS, RVLs score, and RRS combined with RVLs score were 0.860, 0.789, and 0.919, respectively. The predictive power of RRS and RVLs score was comparable, and the predictive power of RRS combined with RVLs score was better than that of RRS and RVLs score.
Conclusion:In AAGN, the predictive power of RRS combined with RVLs score for renal prognosis was better than either RRS or RVLs score, which may serve as a new predictor.


Key words: antineutrophil cytoplasmic antibody-associated glomerulonephritis, renal risk score, renal vascular lesions score, renal prognosis